Literature DB >> 10649972

Antitumor agents. 199. Three-dimensional quantitative structure-activity relationship study of the colchicine binding site ligands using comparative molecular field analysis.

S X Zhang1, J Feng, S C Kuo, A Brossi, E Hamel, A Tropsha, K H Lee.   

Abstract

Inhibitors of tubulin polymerization interacting at the colchicine binding site are potential anticancer agents. We have been involved in the synthesis of a number of colchicine site agents, such as thiocolchicinoids and allocolchicinoids, which are colchicine analogues, and 2-phenyl-quinolones and 2-aryl-naphthyridinones, which are the amino analogues of cytotoxic antimitotic flavonoids. The most cytotoxic of the latter compounds strongly inhibit binding of radiolabeled colchicine to tubulin, and these agents therefore probably bind in the colchicine site of tubulin. We have applied conventional CoMFA and q(2)-GRS CoMFA to identify the essential structural requirements for increasing the ability of these compounds to form tubulin complexes. The CoMFA model for the training set of 51 compounds yielded cross-validated R(2) (q(2)) values of 0.637 for conventional CoMFA and 0.692 for q(2)-GRS CoMFA. The predictive power of this model was confirmed by successful activity prediction for a test set of 53 compounds with known potencies as inhibitors of tubulin polymerization. The activities of 88% of the compounds were predicted with absolute value of residuals of less than 0.5. The predictive q(2) values were 0.546 for conventional CoMFA and 0.426 for q(2)-GRS CoMFA. The conventional CoMFA model with the highest predictive q(2) (0.546) was analyzed in detail in terms of underlying structure-activity relationships.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10649972     DOI: 10.1021/jm990333a

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  3D-QSAR illusions.

Authors:  Arthur M Doweyko
Journal:  J Comput Aided Mol Des       Date:  2004 Jul-Sep       Impact factor: 3.686

2.  Synthesis, molecular modeling and biological evaluation of aza-flavanones as α-glucosidase inhibitors.

Authors:  Sivaprasad Kasturi; Sujatha Surarapu; Chandra Chary Bathoju; Srinivas Uppalanchi; Shubham Dwivedi; Yogeeswari Perumal; Dilep Kumar Sigalapalli; Bathini Nagendra Babu; Krishna S Ethiraj; Jaya Shree Anireddy
Journal:  Medchemcomm       Date:  2017-06-14       Impact factor: 3.597

3.  Asymmetric Methods for the Synthesis of Flavanones, Chromanones, and Azaflavanones.

Authors:  Antoinette E Nibbs; Karl A Scheidt
Journal:  European J Org Chem       Date:  2011-12-09

4.  Probing the opportunities for designing anthelmintic leads by sub-structural topology-based QSAR modelling.

Authors:  Prabodh Ranjan; Mohd Athar; Prakash Chandra Jha; Kari Vijaya Krishna
Journal:  Mol Divers       Date:  2018-04-02       Impact factor: 2.943

5.  Synthesis of an azide-tagged library of 2,3-dihydro-4-quinolones.

Authors:  Hajoong Lee; Masato Suzuki; Jiayue Cui; Sergey A Kozmin
Journal:  J Org Chem       Date:  2010-03-05       Impact factor: 4.354

6.  Antitumor agents 273. Design and synthesis of N-alkyl-thiocolchicinoids as potential antitumor agents.

Authors:  Takashi Kozaka; Kyoko Nakagawa-Goto; Qian Shi; Chin-Yu Lai; Ernest Hamel; Kenneth F Bastow; Arnold Brossi; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem Lett       Date:  2010-05-24       Impact factor: 2.823

7.  Design and synthesis of 2-(3-benzo[b]thienyl)-6,7-methylenedioxyquinolin-4-one analogues as potent antitumor agents that inhibit tubulin assembly.

Authors:  Yu-Hsun Chang; Mei-Hua Hsu; Sheng-Hung Wang; Li-Jiau Huang; Keduo Qian; Susan L Morris-Natschke; Ernest Hamel; Sheng-Chu Kuo; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2009-08-13       Impact factor: 7.446

8.  Palladium-catalyzed asymmetric conjugate addition of arylboronic acids to heterocyclic acceptors.

Authors:  Jeffrey C Holder; Alexander N Marziale; Michele Gatti; Bin Mao; Brian M Stoltz
Journal:  Chemistry       Date:  2012-12-03       Impact factor: 5.236

9.  Design, synthesis, and mechanism of action of 2-(3-hydroxy-5-methoxyphenyl)-6-pyrrolidinylquinolin-4-one as a potent anticancer lead.

Authors:  Yung-Yi Cheng; Chin-Yu Liu; Meng-Tung Tsai; Hui-Yi Lin; Jai-Sing Yang; Tian-Shung Wu; Sheng-Chu Kuo; Li-Jiau Huang; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem Lett       Date:  2013-07-04       Impact factor: 2.823

10.  7-Deacetyl-10-alkylthiocolchicine derivatives - new compounds with potent anticancer and fungicidal activity.

Authors:  Joanna Kurek; Patrycja Kwaśniewska-Sip; Krzysztof Myszkowski; Grzegorz Cofta; Marek Murias; Piotr Barczyński; Beata Jasiewicz; Rafał Kurczab
Journal:  Medchemcomm       Date:  2018-08-16       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.